Menu

My Cart:

0 item(s)

You have no items in your shopping cart.

×

Registration

Profile Informations

Login Datas

or login

First name is required!
Last name is required!
First name is not valid!
Last name is not valid!
This is not an email address!
Email address is required!
This email is already registered!
Password is required!
Enter a valid password!
Please enter 6 or more characters!
Please enter 16 or less characters!
Passwords are not same!
Terms and Conditions are required!
Email or Password is wrong!

 

Expedeon - A Sygnis Company

SYGNIS and Expedeon share a vision of innovation and service by providing cutting edge, patented genomics and proteomics tools to the scientific community. By joining SYGNIS's genomic R&D expertise with Expedeon's proteomic tools and consumables Expedeon will be able to offer a wide variety of innovative products across workflows covering single cell genomics, large scale proteomics and everything in between.

Read the full release here.

Corporate

We have offices, laboratories, and manufacturing facilities in the UK, USA, Spain, Germany and Singapore. We manufacture and sell pre-cast acrylamide gels, protein stains, quantitation reagents, purification resins, protein solubilization reagents and nucleic acid amplification and manipulation products. Expedeon is focused on providing high quality, effective, and rapid solutions for genomic research (especially single cell applications) and proteomics research.

Company Information

Expedeon LTD (UK)
Expedeon Inc. (USA)
Expedeon PTE (Asia)
Unit 12 Buckingway Business Park
Anderson Road
Swavesey
CB24 4AE
United Kingdom
Company Registration No: 4681599
Registered with Companies House in England & Wales
VAT Registration No: GB 815 9377 01
Other contact information and regional addresses are available here.

Board of Directors

Our team is made up of:

  • Dr. Cristina Garmendia Mendizábal, Chairwoman - Dr. Garmendia served as Minister for Science and Innovation of Spain from April 2008 to December 2011, leading some of the most ground-breaking reforms ever made in this area. She also founded Ysios Capital, and is a member of a number of scientific and advisory boards.
  • Mr. Joseph M. Fernández, Member of the Board - Co-founder of Invitrogen, Inc., (currently Life Technologies); founder and CEO/Chairman of Active Motif Inc., which specializes in novel tools and platform technologies for genomics-driven cell biology and epigenetic pathway elucidation.
  • Dr. Franz Wilhelm Hopp, Member of the Board - Partner of LAPLACE Investment GmbH, Munich, Germany. Other mandates include but are not limited to:
    • Member of the Board of Directors of Schneider Golling Bosserhoff VermögensInvest AG, Vaduz, Liechtenstein
    • Member of the NonExecutive Board of Directors of Germany Fund Inc., New Germany Fund Inc., and Central Europe and Russia Fund Inc., New York, USA
  • Ms. María Jesús Sabatés Mas, Member of the Board - Head of the family office of the Sabatés family, Barcelona, Spain. Other mandates include but are not limited to:
    • Sole Administrator of Arceus Holding, S.L., Barcelona, Spain
    • Chairwoman of the Board of Directors of Eurofragance, S.L. , Barcelona, Spain
    • CEO of Ever Smarter WW, S.L., Barcelona, Spain
  • Mr. Tim McCarthy, Member of the Board - Tim has a 35 year international business career in high growth Healthcare, Biotech and Technology companies and is currently Chairman and Non-Executive Director for a number of companies, including Immupharma Plc, Incanthera, Expedeon Holdings and Harvard Healthcare. He has co-founded and been a key player in a number of healthcare and biotechnology companies.
  • Dr. Trevor Jarman, Member of the Board - Dr. Trevor Jarman is an innovative biochemist who has been involved in founding and developing several companies in the life sciences and healthcare arena. He has been Chairman of the Board of Directors of Expedeon Holdings Ltd since its initial founding in 2003, is CEO of Natures Remedies Ltd. and is a member of the Board of Directors for a number of bioscience companies.

 

Business Development

Expedeon is always receptive to any business opportunities and new technologies that will fit within our current range of protein science products. If you or your company have developed or are involved in;

  • Novel Bioscience Technologies
  • Unique or Recently Acquired Technologies
  • Pursuing Out-Licensing Opportunities Involving Novel Products

Then please send an introductory email explaining your situation and goals to info@expedeon.com and a member of our team will be in contact with you.

Current Vacancies

We are always on the lookout for high-calibre people who would be able to work within our highly motivated and rapidly expanding team. If there are no specific vacancies posted on our Employment page or listed below, then please feel free to e-mail your CV and covering letter to info@expedeon.com giving us a summary of your experiences and achievements to-date and what you are able to offer us.  We shall, of course, treat all enquiries and CV submissions as strictly confidential.